Latest Breaking News On - European pharmacovigilance risk assessment committee - Page 1 : comparemela.com

MHRA Chief Executive to step down

MHRA Chief Executive to step down
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

United kingdomRalf liebhold shutterstockDame june raineGraham cookeRegulatory agencyAdvisory committee on safety of medicinal productsChair of the world health organizationEuropean pharmacovigilance risk assessment committeeChief executiveRalf liebholdDame juneChief executive officerRisk managementWorld health organizationAdvisory committee

What we know about the Guillain-Barré syndrome epidemic in Peru

What we know about the Guillain-Barré syndrome epidemic in Peru
odnako.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from odnako.org Daily Mail and Mail on Sunday newspapers.

United statesFrench polynesiaUnited kingdomÎe de franceFrance generalSaint quentin en yvelinesNicolas weissMahmoud zureikHigh authorityNational agency for the safety of medicinesPeruvian ministry of healthMinistry of healthEuropean medicines agencyUniversity of versaillesEuropean pharmacovigilance risk assessment committeeWorld health organization

Pholcodine cough medicines removed from Namibian shelves

Pholcodine cough medicines removed from Namibian shelves
namibian.com.na - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from namibian.com.na Daily Mail and Mail on Sunday newspapers.

South africaUnited kingdomFransina nambahuBen nangombeAfrica health products regulatory authorityWorld health organisationNational pharmaceutical regulatory agency of malaysiaEuropean medicine agencyNamibia medicines regulatory councilMinistry of healthHealthcare products regulatory agencyTherapeutic goods administration of australiaEuropean pharmacovigilance risk assessment committeeHealth products regulatory authorityTherapeutic goods administrationNational pharmaceutical regulatory agency

Cureus | Measures to Mitigate Sodium Valproate Use in Pregnant Women With Epilepsy

Sodium valproate is a sodium salt of valproic acid. It is often used in the medical treatment of several conditions like epilepsy, bipolar disorder, mania, and migraines. This review debates whether the usage of valproic acid is appropriate in pregnancy. It also lists the various neonatal deformities and other teratogenic effects the said drug presents due to prenatal exposure to the drug and the implications of continuing drug therapy in certain situations. We should often weigh the outcomes and implement it only in conditions where its use is inevitable. It also includes the importance of awareness among middle-aged women with mental illness regarding the teratogenic effects of sodium valproate use and the relevance of discussion by physicians with patients regarding the usage of this drug despite being aware of the complications. It also explores other treatment options and modalities that can be used in the place of valproic acid for epilepsy and bipolar disorder in pregnant women

United statesFrance generalUnited kingdomNational institute for healthCentre of perinatal excellenceEuropean medical associationEuropean pharmacovigilance risk assessment committeeEuropean medicines agencyRev neurolEuropean medicinesNorth americanWestern capePerinatal excellenceNational instituteCare excellence